Cargando…
Comparison of revised EWGSOP2 criteria of sarcopenia in patients with cancer using different parameters of muscle mass
Calf circumference (CC) has been established as a marker of muscle mass (MM) with good performance for predicting survival in individuals with cancer. The study aims to determine the prevalence of sarcopenia according to the European Working Group on Sarcopenia in Older People 2 (EWGSOP2) criteria a...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439478/ https://www.ncbi.nlm.nih.gov/pubmed/34520502 http://dx.doi.org/10.1371/journal.pone.0257446 |
_version_ | 1783752533599059968 |
---|---|
author | Trussardi Fayh, Ana Paula de Sousa, Iasmin Matias |
author_facet | Trussardi Fayh, Ana Paula de Sousa, Iasmin Matias |
author_sort | Trussardi Fayh, Ana Paula |
collection | PubMed |
description | Calf circumference (CC) has been established as a marker of muscle mass (MM) with good performance for predicting survival in individuals with cancer. The study aims to determine the prevalence of sarcopenia according to the European Working Group on Sarcopenia in Older People 2 (EWGSOP2) criteria and to evaluate the accuracy of sarcopenia using low CC relative to MM assessment by computed tomography (CT) at third lumbar vertebra level (L3) as a reference. Cross-sectional study with cancer patients aged ≥ 60 years. Data included socio-demographic, clinical and anthropometric variables. MM was assessed by CC and by CT images at the L3. Sarcopenia was diagnosed according to the EWGSOP2 criteria: a) low handgrip strength (HGS) + reduced MM evaluated by CT; and b) low HGS + low CC. Pearson’s correlation, accuracy, sensitivity, specificity, positive predictive and negative predictive value were analyzed. A total of 108 patients were evaluated, age of 70.6 ± 7.4 years (mean ± standard deviation). The prevalence of sarcopenia was of 24.1% (low MM) and 25.9% (low CC). The Kappa test showed a substantial agreement (K = 0.704), 81% sensitivity, and 92% specificity. Although the EWGSOP2 advises that we should use CC measures in the algorithm for sarcopenia when no other MM diagnostic methods are available, the findings allow the use of CC instead of MM by CT in cancer patients. |
format | Online Article Text |
id | pubmed-8439478 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-84394782021-09-15 Comparison of revised EWGSOP2 criteria of sarcopenia in patients with cancer using different parameters of muscle mass Trussardi Fayh, Ana Paula de Sousa, Iasmin Matias PLoS One Research Article Calf circumference (CC) has been established as a marker of muscle mass (MM) with good performance for predicting survival in individuals with cancer. The study aims to determine the prevalence of sarcopenia according to the European Working Group on Sarcopenia in Older People 2 (EWGSOP2) criteria and to evaluate the accuracy of sarcopenia using low CC relative to MM assessment by computed tomography (CT) at third lumbar vertebra level (L3) as a reference. Cross-sectional study with cancer patients aged ≥ 60 years. Data included socio-demographic, clinical and anthropometric variables. MM was assessed by CC and by CT images at the L3. Sarcopenia was diagnosed according to the EWGSOP2 criteria: a) low handgrip strength (HGS) + reduced MM evaluated by CT; and b) low HGS + low CC. Pearson’s correlation, accuracy, sensitivity, specificity, positive predictive and negative predictive value were analyzed. A total of 108 patients were evaluated, age of 70.6 ± 7.4 years (mean ± standard deviation). The prevalence of sarcopenia was of 24.1% (low MM) and 25.9% (low CC). The Kappa test showed a substantial agreement (K = 0.704), 81% sensitivity, and 92% specificity. Although the EWGSOP2 advises that we should use CC measures in the algorithm for sarcopenia when no other MM diagnostic methods are available, the findings allow the use of CC instead of MM by CT in cancer patients. Public Library of Science 2021-09-14 /pmc/articles/PMC8439478/ /pubmed/34520502 http://dx.doi.org/10.1371/journal.pone.0257446 Text en © 2021 Trussardi Fayh, de Sousa https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Trussardi Fayh, Ana Paula de Sousa, Iasmin Matias Comparison of revised EWGSOP2 criteria of sarcopenia in patients with cancer using different parameters of muscle mass |
title | Comparison of revised EWGSOP2 criteria of sarcopenia in patients with cancer using different parameters of muscle mass |
title_full | Comparison of revised EWGSOP2 criteria of sarcopenia in patients with cancer using different parameters of muscle mass |
title_fullStr | Comparison of revised EWGSOP2 criteria of sarcopenia in patients with cancer using different parameters of muscle mass |
title_full_unstemmed | Comparison of revised EWGSOP2 criteria of sarcopenia in patients with cancer using different parameters of muscle mass |
title_short | Comparison of revised EWGSOP2 criteria of sarcopenia in patients with cancer using different parameters of muscle mass |
title_sort | comparison of revised ewgsop2 criteria of sarcopenia in patients with cancer using different parameters of muscle mass |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439478/ https://www.ncbi.nlm.nih.gov/pubmed/34520502 http://dx.doi.org/10.1371/journal.pone.0257446 |
work_keys_str_mv | AT trussardifayhanapaula comparisonofrevisedewgsop2criteriaofsarcopeniainpatientswithcancerusingdifferentparametersofmusclemass AT desousaiasminmatias comparisonofrevisedewgsop2criteriaofsarcopeniainpatientswithcancerusingdifferentparametersofmusclemass |